Relationship between postmenopausal hormone replacement therapy and ovarian cancer.

Relationship between postmenopausal hormone replacement therapy and ovarian cancer.

Pokaż inne wersje (1)

Opis bibliograficzny
Główni autorzy:	Bosetti, C, Negri, E, Franceschi, S, Trichopoulos, D, Beral, V, La Vecchia, C
Format:	Journal article
Język:	English
Wydane:	2001

Podobne zapisy

Relationship between postmenopausal hormone replacement therapy and ovarian cancer
od: Bosetti, C, i wsp.
Wydane: (2001)

Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
od: Negri, E, i wsp.
Wydane: (1999)

Long-term effects of oral contraceptives on ovarian cancer risk.
od: Bosetti, C, i wsp.
Wydane: (2002)

Hormone replacement therapy and ovarian cancer.
od: Beral, V, i wsp.
Wydane: (1991)

HORMONE REPLACEMENT THERAPY AND OVARIAN-CANCER
od: Beral, V, i wsp.
Wydane: (1991)

False alarm: postmenopausal hormone therapy and ovarian cancer - Response
od: Beral, V, i wsp.
Wydane: (2007)

Ovarian cancer and hormone replacement therapy - Reply
od: Beral, V, i wsp.
Wydane: (2007)

Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause.
od: Franceschi, S, i wsp.
Wydane: (1991)

Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.
od: Franceschi, S, i wsp.
Wydane: (1991)

Ovarian cancer and hormone replacement therapy in the Million Women Study.
od: Beral, V, i wsp.
Wydane: (2007)

Hormone replacement therapy increase breast cancer incidence and may increase breast cancer mortality in postmenopausal women
od: Beral, V, i wsp.
Wydane: (2004)

Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer.
od: Negri, E, i wsp.
Wydane: (1991)

Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.
od: Beral, V, i wsp.
Wydane: (2005)

Antioxidant effects of hormone replacement therapy in postmenopausal women
od: T Delibasi, i wsp.
Wydane: (2006-08-01)

Impact of hormone replacement therapy on breast cancer
od: Gathani, T, i wsp.
Wydane: (2010)

POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY; CHANGES OF THE MAMMOGRAPHIC FINDINGS
od: Ayşegül Sarsılmaz, i wsp.
Wydane: (2009-01-01)

Hormone replacement therapy in postmenopause - where we stand?
od: Damir Franić
Wydane: (2007-02-01)

Hormone replacement therapy in prevention and treatment of postmenopausal osteoporosis
od: Rajesh Hishikar, i wsp.
Wydane: (2014-01-01)

INFLUENCE OF LOCAL HORMONE REPLACEMENT THERAPY ON MICTURITIONDISORDERS IN POSTMENOPAUSE
od: Adolf Lukanovič
Wydane: (2008-12-01)

Breast cancer and hormone-replacement therapy in the Million Women Study.
od: Beral, V
Wydane: (2003)

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study.
od: Liu, B, i wsp.
Wydane: (2008)

Hormone replacement therapy
od: Grant, C, i wsp.
Wydane: (1999)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
od: Beral, V, i wsp.
Wydane: (1997)

HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSE AND CARDIOVASCULAR DISEASES: FACTS AND DILEMMAS
od: Branka Žegura, i wsp.
Wydane: (2018-02-01)

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study
od: Liu, B, i wsp.
Wydane: (2008)

The Relationship Between Hormone Therapy and Vaginal Candidiasis in Postmenopausal Patients
od: Hüseyin Özyurt, i wsp.
Wydane: (2008-08-01)

Endometrial cancer and hormone-replacement therapy in the Million Women Study.
od: Beral, V, i wsp.
Wydane: (2005)

Protective effect of postmenopausal hormone replacement against urolithiasis
od: C. Tsai, i wsp.
Wydane: (2020-07-01)

Hormone replacement therapy effectiveness and safety in postmenopausal women with metabolic syndrome
od: O. N. Poryvkina, i wsp.
Wydane: (2009-02-01)

Modification of blood pressure in postmenopausal women: role of hormone replacement therapy
od: Cannoletta M, i wsp.
Wydane: (2014-08-01)

Predicting the effectiveness of hormone replacement therapy in postmenopausal osteoporotic changes correction
od: I S Zakharov, i wsp.
Wydane: (2015-08-01)

Can hormonal replacement therapy be a solution for postmenopausal women with nocturia?
od: K. Pauwaert, i wsp.
Wydane: (2020-07-01)

Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women.
od: Banks, E, i wsp.
Wydane: (2004)

Tobacco smoking, smoking cessation, and cumulative risk of upper aerodigestive tract cancers.
od: Bosetti, C, i wsp.
Wydane: (2008)

Hormone replacement therapy for postmenopausal atherosclerosis is offset by late age iron deposition
od: Tianze Xu, i wsp.
Wydane: (2023-08-01)

Effects of hormone replacement therapy and tibolone on skin thickness and bone in postmenopausal women
od: Demir Berfu, i wsp.
Wydane: (2006-01-01)

Effect of hormone replacement therapy on lipids and coagulation factors in postmenopausal women smokers
od: Tatović-Babić Danijela, i wsp.
Wydane: (2002-01-01)

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
od: Beral, V, i wsp.
Wydane: (2003)

Long-term effects of hormone replacement therapy - Reply
od: Beral, V, i wsp.
Wydane: (2003)

Hormone replacement therapy for secondary prevention of coronary heart disease.
od: Banks, E, i wsp.
Wydane: (1999)